- Feds Announce New Measures to Monitor, Prevent Bird Flu
- His Cancer Journey Shows Health Dangers Firefighters Face
- Baby Girl Born Deaf Gains Hearing After Gene Therapy
- Cyberattack Cripples Major U.S. Health Care Network
- Cancer Patients Often Face Medical Debt, Even With Insurance
- One in 8 U.S. Adults Have Now Used Blockbuster Meds Like Ozempic
- Pushing the Body in ‘Extreme’ Sports Won’t Shorten Life Span
- Utah Kids Got E. Coli From Playing Around Lawn Sprinklers
- Getting Help for Alcohol, Drug Abuse Tougher for Rural Americans
- Outdoor Workers Face Skin Cancer Danger
CVS Pulling Popular Cold Meds From Shelves After Report Deems Them to Be Useless
CVS Health plans to pull cold medications that contain phenylephrine from its store shelves after federal regulators determined recently that the decongestant doesn’t work.
Oral phenylephrine is an active ingredient in such well-known products as Sudafed and Dayquil. An FDA advisory committee ruled last month that the ingredient was useless in easing congestion.
“We are removing certain oral cough and cold products that contain phenylephrine as the only active ingredient from CVS Pharmacy stores,” the company told CBS MoneyWatch.
“Other oral cough and cold products will continue to be offered to meet consumer needs,” the company added.
Another drugstore chain, Walgreens, said it “follows FDA [U.S. Food and Drug Administration] regulations,” but did not say if it would stop selling the medications.
“We are closely monitoring the situation and actively partnering with the Walgreens Office of Clinical Integrity and suppliers on appropriate next steps,” a spokesperson told CBS MoneyWatch.
Medications that contain phenylephrine account for $1.8 billion in annual sales, according to FDA data.
More information
The National Library of Medicine has more on phenylephrine.
SOURCE: CBS News, Oct. 19, 2023
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.